PINPOINT

DEVICE2 trials

Sponsors

Novadaq Technologies ULC, now a part of Stryker

Conditions

Cervical CancerEndometrial CancerRectal CancerRectosigmoid CancerUterine Cancer

Unknown Phase

A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection

TerminatedNCT02205307

Novadaq Technologies ULC, now a part of StrykerRectal Cancer, Rectosigmoid Cancer

Start: 2015-01-31End: 2017-05-31Updated: 2020-06-24

A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

CompletedNCT02209532

Novadaq Technologies ULC, now a part of StrykerCervical Cancer, Endometrial Cancer, Uterine Cancer

Start: 2015-12-31End: 2017-06-30Updated: 2019-03-25

Related Papers

The problem of colorectal anastomosis safety

Medicine2020-01-0126 citations

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.

2018-08-22230 citations